WeVote
Log In

Bill

Bill

SB 1768

Stem Cell Therapy

2025 Regular Session Introduced by Jay Trumbull

Florida enacts regulatory framework for stem cell therapies, establishing state oversight standards for clinical applications of emerging stem cell treatments.

Chapter No. 2025-185
#subjectindex
0
WeVote Research Nonpartisan
Bill Summary · SB 1768

Legislative bill overview

SB 1768 establishes a regulatory framework for stem cell therapies in Florida, creating standards for clinical applications and oversight mechanisms. The bill was unanimously passed by the Florida Senate and signed into law in June 2025, becoming Chapter 2025-185.

Why is this important

Stem cell therapies represent a rapidly growing medical frontier with significant potential for treating degenerative diseases, but also carry risks of unproven treatments and patient exploitation. This legislation provides Florida with explicit state-level governance over an emerging medical field, potentially positioning the state as either a leader in regulated innovation or a destination for experimental treatments depending on implementation.

Potential points of contention

  • Regulatory stringency vs. innovation balance: The bill's specific requirements for clinical oversight and approval processes may either protect patients from unproven therapies or create barriers that slow access to potentially beneficial treatments
  • Federal-state jurisdiction overlap: Stem cell research and therapies already fall under FDA regulation; unclear how state standards interact with federal authority and whether they create duplicate or conflicting requirements
  • Access and equity concerns: Depending on licensing costs and approval timelines, the regulatory framework could concentrate stem cell treatments among wealthy patients or certain providers, raising fairness questions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.